Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
- 27 July 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 20 (10), 1690-1700
- https://doi.org/10.1038/sj.leu.2404335
Abstract
Allogeneic hematopoietic cell transplantation (HCT) following nonmyeloablative conditioning has been extensively evaluated in patients with hematologic malignancies who are ineligible for conventional HCT because of age or medical comorbidities. Nonmyeloablative regimens have led to an initial state of mixed hematopoietic chimerism defined as coexistence of donor- and host-derived hematopoiesis. While nonmyeloablative regimens have been associated with reduced regimen-related toxicities in comparison with conventional myeloablative conditioning, graft rejection, graft-versus-host disease (GVHD), and disease progression have remained significant challenges. In this article, after briefly introducing current techniques for chimerism assessment, we describe factors affecting donor chimerism levels after nonmyeloablative conditioning, and then review data suggesting that chimerism assessment early after HCT might help identify patients at risk for graft rejection, GVHD and relapse/progression. Finally, we discuss how these observations have opened the way to further research protocols evaluating manipulation of postgrafting immunosuppression, and/or infusion of donor immune cells.This publication has 85 references indexed in Scilit:
- High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTBlood, 2006
- Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationBlood, 2005
- Evaluation and Automation of Hematopoietic Chimerism Analysis Based on Real-Time Quantitative Polymerase Chain ReactionTransplantation and Cellular Therapy, 2005
- Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamideBlood, 2005
- How and when should we monitor chimerism after allogeneic stem cell transplantation?Bone Marrow Transplantation, 2004
- Evaluation of STR informativity for chimerism testing – comparative analysis of 27 STR systems in 203 matched related donor recipient pairsLeukemia, 2003
- Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejectionLeukemia, 2003
- Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioningBone Marrow Transplantation, 2003
- Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantationBlood, 2003